SCHEMBL2267254

SCHEMBL2267254

CC(=O)N(Cl)c1ccc2c(c1NC(=O)c1ccno1)C(=O)c1ccccc1C2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.42
MEN1 O00255 6/20 0.40
CSF1R P07333 1/20 0.38
MAPT P10636 7/20 0.37
MAPK1 P28482 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 1/20 0.37
MMP14 P50281 1/20 0.37
MAOA P21397 2/20 0.37
GAA P10253 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HDAC1 Q13547 1/20 0.36
PKM P14618 1/20 0.35
PYGM P11217 1/20 0.35
NSD2 O96028 1/20 0.34
EGFR P00533 1/20 0.34
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PABPC1 P11940 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2269578 0.83 RAB9A (0.41) KMT2AMAPTMAPK1SMN1; SMN2KDM4E
SCHEMBL2272381 0.82 ACE2 (0.47) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2274384 0.80 MAPT (0.44) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2268881 0.80 PTPRC (0.47) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2273092 0.79 ALDH1A1 (0.46) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2269057 0.79 ALDH1A1 (0.41) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2274863 0.79 ALDH1A1 (0.55) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2274343 0.79 ALDH1A1 (0.46) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2272438 0.78 TP53 (0.40) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL2270248 0.78 MAPK14 (0.43) KMT2AMEN1MAPTKDM4EMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530465-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2013-09-10 US claimed
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof HUANG HSU-SHAN (TW) 2013-03-07 US claimed
US-8530465-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2013-09-10 US disclosed
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof HUANG HSU-SHAN (TW) 2013-03-07 US disclosed
US-8304415-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2012-11-06 US disclosed
US-20110207739-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207739-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof ANXA1, ANXA5, ANXA2 KMT2A 3021/4885MEN1 485/4885CSF1R 3835/4885
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof ANXA5, ANXA1, HCCS KMT2A 2601/4885MEN1 847/4885CSF1R 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.